The notices it replaced
- Reissues: PAR-18-654 Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
- 2 steps back: PAR-15-093 Basic Cancer Research in Cancer Health Disparities (R01)
Replaced by PAR-24-277.
Who won it before
91 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $44,164,824 in first-year total cost, median $469,544.
Most frequent study sections
- Basic Mechanisms of Cancer Health Disparities Study Section[BMCD]27
- Special Emphasis Panel[ZRG1 OBT-B (55)]23
- Special Emphasis Panel[ZRG1 OBT-Y (55)]18
- Special Emphasis Panel[ZRG1 OBT-K (55)]7
- Special Emphasis Panel[ZRG1 OBT-A (55)]4
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE5
- OHIO STATE UNIVERSITY5
- CASE WESTERN RESERVE UNIVERSITY4
- JOHNS HOPKINS UNIVERSITY4
- UNIVERSITY OF ALABAMA AT BIRMINGHAM4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | The biological mechanisms of racial disparity in head and neck cancer1R01CA290401-01A1 | MOMEN HERAVI, FATEMEH | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $714,062 | BMCD |
| 2025 | Socioeconomic and adversity-associated immunobiologic influences on pediatric hematopoietic cell transplant outcomes1R01CA298935-01 | KNIGHT, JENNIFER MARYTURCOTTE, LUCIE MARIE | UNIVERSITY OF MINNESOTA, MN | $676,550 | BMCD |
| 2025 | Racial Disparities in the Mechanisms of Prostate Cancer Metastasis1R01CA295722-01 | MORENO, CARLOS SANCHEZ | EMORY UNIVERSITY, GA | $659,498 | BMCD |
| 2025 | Strategies to Reduce Global Health Disparities in Cervical Cancer1R01CA295696-01 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $630,506 | BMCD |
| 2025 | Racial Difference in Prostate Cancer2R01CA220327-06 | FREEDLAND, STEPHEN JAYFREEMAN, MICHAEL R. | CEDARS-SINAI MEDICAL CENTER, CA | $460,263 | ZRG1 |
| 2025 | Molecular mediators of disparate outcomes experienced by patients of African ancestry with lung cancer1R37CA295609-01 | MCGRAIL, DANIEL JAMES | CLEVELAND CLINIC LERNER COM-CWRU, OH | $368,288 | BMCD |
| 2025 | Subclonal p27 Loss and Altered Tumor Immune Microenvironment as a Driver of Fatal Prostate Cancer1R01CA288760-01A1 | SFANOS, KAREN SANDELL | JOHNS HOPKINS UNIVERSITY, MD | $354,658 | BMCD |
| 2024 | Understanding lung cancer genomics in patients of African ancestry1R01CA286469-01A1 | ZHANG, JIAN | SLOAN-KETTERING INST CAN RESEARCH, NY | $730,398 | BMCD |
| 2024 | Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors1R01CA285599-01A1 | HILDEBRANDT, MICHELLE A T | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $692,417 | BMCD |
| 2024 | MIZ1 Activation in Triple-negative Breast Cancer Racial Disparities1R01CA275910-01A1 | HUANG, ALEX YEE-CHENSCHIEMANN, WILLIAMZHU, XIAOFENG | CASE WESTERN RESERVE UNIVERSITY, OH | $617,723 | BMCD |
| 2024 | Tumor and Host Immune signatures associated with health disparities in outcomes following GD2 immunotherapy in neuroblastoma1R01CA285566-01A1 | DHODAPKAR, KAVITA MADHAVGOLDSMITH, KELLY C | EMORY UNIVERSITY, GA | $576,659 | BMCD |
| 2024 | Aberrant Activation of Androgen Signaling Pathways in African American Prostate Cancer1R01CA288392-01 | SUN, ZIJIE | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $539,633 | BMCD |
| 2024 | Genomic bases for African geo-ethnic prostate cancer health disparity1R01CA285772-01 | HAYES, VANESSA MARIE | UNIVERSITY OF SYDNEY | $500,626 | BMCD |
| 2024 | Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial Disparity1R01CA292020-01 | GANJU, RAMESH K. | OHIO STATE UNIVERSITY, OH | $469,544 | BMCD |
| 2024 | Men of African Ancestry are primed for aggressive prostate cancer by high prostate androgens driven by vitamin D deficiency and megalin1R01CA290811-01 | NONN, LARISA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $366,242 | BMCD |
| 2024 | Understanding the biology of disparity-associated genomically stable gastric tumors1R56CA280636-01A1 | CARVAJAL CARMONA, LUIS GUILLERMO | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $241,500 | BMCD |
| 2023 | Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people1R01CA280639-01 | HUYGHE, JEROEN RPETERS, ULRIKEREDWOOD, DIANA | FRED HUTCHINSON CANCER CENTER, WA | $705,264 | BMCD |
| 2023 | Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities1R01CA285446-01 | BITLER, BENJAMIN GSIKORA, MATTHEW J | UNIVERSITY OF COLORADO DENVER, CO | $645,565 | BMCD |
| 2023 | Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.1R01CA282282-01 | GAO, JIANJUNPUTLURI, NAGIREDDYSIDDIQUI, MOHUMMAD MINHAJ | BAYLOR COLLEGE OF MEDICINE, TX | $645,401 | BMCD |
| 2023 | Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities1R01CA264525-01A1 | CAMP, ERNEST RAMSAYRUBINSTEIN, MARK P | OHIO STATE UNIVERSITY, OH | $642,846 | BMCD |
| 2023 | Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer1R01CA272702-01A1 | KIM, HARRISONSUNG, KYUNG HYUN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $577,780 | BMCD |
| 2023 | Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies1R01CA272627-01A1 | FURDUI, CRISTINA MARIALIU, LIANGZHANG, WEI | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $555,770 | BMCD |
| 2023 | Novel targeted therapy to reduce health disparities in pediatric leukemia1R01CA278226-01 | DOVAT, SINISA | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $541,022 | ZRG1 |
| 2023 | Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men1R01CA276474-01 | LIU, XUEFENG | OHIO STATE UNIVERSITY, OH | $537,842 | ZRG1 |
| 2023 | Protein kinase C signaling in prostate cancer health disparities1R01CA276082-01A1 | KAZANIETZ, MARCELO G. | UNIVERSITY OF PENNSYLVANIA, PA | $488,027 | BMCD |
| 2023 | Role of YB1 in health disparities in triple negative breast cancer1R01CA272621-01A1 | SOSSEY-ALAOUI, KHALID | CASE WESTERN RESERVE UNIVERSITY, OH | $481,625 | BMCD |
| 2023 | Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma1R01CA259415-01A1 | TURNER, DAVID PAUL | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $481,094 | ZRG1 |
| 2023 | SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction1R01CA279170-01 | JIAO, KAIWANG, LIZHONG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $478,030 | BMCD |
| 2023 | SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.1R01CA276482-01A1 | KASTRATI, IRIDA | LOYOLA UNIVERSITY CHICAGO, IL | $465,767 | BMCD |
| 2023 | Immunogenetics of Outcomes Disparities After Allogeneic HCT2R01CA231838-07 | PETERSDORF, EFFIE W | FRED HUTCHINSON CANCER CENTER, WA | $442,860 | BMCD |
| 2023 | Development of blood-based methylation biomarkers for CRC risk prediction1R01CA281948-01 | GHOSH, JAYASHRI | TEMPLE UNIV OF THE COMMONWEALTH, PA | $390,661 | BMCD |
| 2023 | Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences1R01CA275089-01A1 | XI, YAGUANGYU, QINGZHAO | LSU HEALTH SCIENCES CENTER, LA | $336,263 | ZRG1 |
| 2023 | Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes1R56CA284564-01 | HENG, YU JING JANWULF, GERBURG M | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $299,940 | ZRG1 |
| 2022 | Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans1R01CA248923-01A1 · under PAR-18-654 | ELLISEN, LEIF WKO, NAOMI YU | MASSACHUSETTS GENERAL HOSPITAL, MA | $751,170 | ZRG1 |
| 2022 | Determining the role of germline CDH1 variants in gastric cancer outcome disparities in Hispanic/Latino patients1R37CA265967-01A1 | WANG, SAM C. | UT SOUTHWESTERN MEDICAL CENTER, TX | $702,611 | ZRG1 |
| 2022 | Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy1R37CA264518-01A1 | YAMOAH, KOSJ | H. LEE MOFFITT CANCER CTR & RES INST, FL | $684,576 | ZRG1 |
| 2022 | The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora1R01CA266040-01 · under PAR-18-654 | GARDNER, KEVIN L. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $649,645 | ZRG1 |
| 2022 | Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors1R01CA266052-01A1 | KOFF, JEAN LSINGH, ANKUR | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $563,593 | ZRG1 |
| 2022 | The Microbiome and Mucosal Immunity in Cervical Cancer Disparities1R01CA266050-01 · under PAR-18-654 | AVRIL, STEFANIEBURGENER, ADAM | CASE WESTERN RESERVE UNIVERSITY, OH | $559,473 | ZRG1 |
| 2022 | Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes1R01CA266041-01 · under PAR-18-654 | LIU, YINGSHAO, JIEYA | WASHINGTON UNIVERSITY, MO | $513,768 | ZRG1 |
| 2022 | Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma1R01CA265975-01A1 | SIDRANSKY, DAVIDTOLAND, AMANDA EWART | JOHNS HOPKINS UNIVERSITY, MD | $489,635 | ZRG1 |
| 2022 | Targeting centrosome‐mitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.1R01CA266046-01A1 | CRESS, WILLIAM DOUGLASSAAVEDRA, HAROLD I | PONCE SCHOOL OF MEDICINE, PR | $483,219 | ZRG1 |
| 2022 | Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function1R01CA267090-01 · under PAR-18-654 | RUSTVELD, LUISSREEKUMAR, ARUN | BAYLOR COLLEGE OF MEDICINE, TX | $464,326 | ZRG1 |
| 2022 | Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations1R37CA266042-01 · under PAR-18-654 | PANNUNZIO, NICHOLAS | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $421,097 | ZRG1 |
| 2022 | Targeted delivery of multimodal therapy for reducing prostate cancer disparity1R01CA265937-01 · under PAR-18-654 | LIU, RUNHUA RUNAZHOU, JIANGBING | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $386,974 | ZRG1 |
| 2022 | Biological Indicators of Racial Disparity in Ameloblastoma Recurrence1R01CA259307-01A1 · under PAR-18-654 | AKINTOYE, SUNDAY O | UNIVERSITY OF PENNSYLVANIA, PA | $371,719 | ZRG1 |
| 2022 | Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer1R01CA260351-01A1 · under PAR-18-654 | AGRAWAL, ANSHULILLY, MICHAEL BZI, XIAOLIN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $370,628 | ZRG1 |
| 2021 | Variation in tumor-associated immune profiles and colorectal cancer outcomes1R01CA248931-01A1 · under PAR-18-654 | SCHMIT, STEPHANIE L. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $736,864 | ZRG1 |
| 2021 | Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort1R01CA259420-01 · under PAR-18-654 | PURRINGTON, KRISTEN S.ROZEK, LAURASTOFFEL, ELENA MARTINEZ | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $655,222 | ZRG1 |
| 2021 | Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer1R01CA248920-01A1 · under PAR-18-654 | CAMPBELL, JOSHUA D | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $610,293 | ZRG1 |
| 2021 | P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities1R01CA253450-01A1 · under PAR-18-654 | HOADLEY, KATHERINE A.TROESTER, MELISSA A. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $597,226 | ZRG1 |
| 2021 | Inactivation of MSH3 in Colorectal Cancer and Race1R01CA258519-01 · under PAR-18-654 | ASHKTORAB, HASSANCARETHERS, JOHN M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $579,469 | ZRG1 |
| 2021 | Molecular Determinants of Health Disparities in Inflammatory Breast Cancer1R01CA264529-01 · under PAR-18-654 | DEVI, GAYATHRI | DUKE UNIVERSITY, NC | $518,284 | ZRG1 |
| 2021 | The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response1R01CA259396-01 · under PAR-18-654 | DAVIS, MELISSA BNEWMAN, LISA A. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $517,362 | ZRG1 |
| 2021 | Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer1R01CA264519-01 · under PAR-18-654 | COHN, BARBARA AJONES, DEAN PAUL | PUBLIC HEALTH INSTITUTE, CA | $491,293 | ZRG1 |
| 2021 | TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients1R01CA248930-01A1 · under PAR-18-654 | BHATNAGAR, SANCHITA | UNIVERSITY OF VIRGINIA, VA | $140,093 | ZRG1 |
| 2020 | The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities1R01CA253368-01 · under PAR-18-654 | GARDNER, KEVIN L. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $672,210 | ZRG1 |
| 2020 | Collagen Sequence Variants in Racial Disparities of Breast Cancer1R01CA253460-01 · under PAR-18-654 | ANGEL, PEGGI M | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $552,568 | ZRG1 |
| 2020 | Epigenetic dysregulation in APC-negative colorectal cancer1R01CA242914-01A1 · under PAR-18-654 | ELLIS, NATHAN A.LLOR, XAVIER | UNIVERSITY OF ARIZONA, AZ | $541,456 | ZRG1 |
| 2020 | Discovery and therapeutic targeting of biological determinants of lung cancer health disparities1R01CA239093-01A1 · under PAR-18-654 | PINE, SHARON R. | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $416,907 | ZRG1 |
| 2020 | RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER1R01CA253445-01 · under PAR-18-654 | KAIPPARETTU, BENNY ABRAHAM | BAYLOR COLLEGE OF MEDICINE, TX | $381,240 | ZRG1 |
| 2020 | Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer1R01CA253312-01 · under PAR-18-654 | CLARKE, JEFFREY MELSONFREEDMAN, JENNIFER ANNGRAY, JHANELLE E. | DUKE UNIVERSITY, NC | $377,130 | ZRG1 |
| 2020 | Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women1R01CA242917-01A1 · under PAR-18-654 | LIU, RUNHUA RUNALIU, XIAOGUANG MARGARETWANG, LIZHONG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $339,694 | ZRG1 |
| 2019 | Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins1R01CA238087-01 · under PAR-18-654 | FIGUEIREDO, JANE C.SCHMIT, STEPHANIE L. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $727,816 | ZRG1 |
| 2019 | Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities1R01CA238061-01 · under PAR-18-654 | RAGIN, CAMILLE C.SOBOL, ROBERT W | RESEARCH INST OF FOX CHASE CAN CTR, PA | $667,865 | ZRG1 |
| 2019 | HSET as a racial disparity biomarker for TNBC patients1R01CA239120-01 · under PAR-18-654 | ANEJA, RITU | GEORGIA STATE UNIVERSITY, GA | $612,894 | ZRG1 |
| 2019 | Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer1R01CA231857-01A1 · under PAR-18-654 | GANJU, RAMESH K.RAMASWAMY, BHUVANESWARI | OHIO STATE UNIVERSITY, OH | $441,049 | ZRG1 |
| 2019 | Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction1R01CA227559-01A1 · under PAR-18-654 | PALAPATTU, GANESH SSREEKUMAR, ARUN | BAYLOR COLLEGE OF MEDICINE, TX | $408,656 | ZRG1 |
| 2019 | Functional Consequences of Racially Associated Ephrin Alterations on the Prostate Tumor Microenvironment1R01CA242920-01 · under PAR-18-654 | FRANCO CORONEL, OMAR | ENDEAVOR HEALTH CLINICAL OPERATIONS, IL | $375,117 | ZRG1 |
| 2019 | Aggressive prostate cancer of African Americans is correlated with regulation of Immunoregulatory Genes in stroma1R01CA226570-01A1 · under PAR-18-654 | RAHMATPANAH, FARAH BAKHSHIAN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $353,419 | ZRG1 |
| 2019 | Prostate Cancer Health Disparity: Role of PDEF1R01CA242839-01 · under PAR-18-654 | KOUL, HARI K | LOUISIANA STATE UNIV HSC SHREVEPORT, LA | $333,975 | ZRG1 |
| 2018 | Immunogenetics of Outcomes Disparities after Allogeneic HCT1R01CA231838-01 · under PAR-15-093 | PETERSDORF, EFFIE W | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $409,042 | ZRG1 |
| 2018 | Racial Differences in Prostate Cancer Molecular Subtyping1R01CA220327-01A1 · under PAR-15-093 | FREEDLAND, STEPHEN JAYFREEMAN, MICHAEL R | CEDARS-SINAI MEDICAL CENTER, CA | $400,313 | ZRG1 |
| 2018 | Genomics of HCC in the Hispanic population of Texas1R01CA204665-01A1 · under PAR-15-093 | BERETTA, LAURA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $390,463 | ZRG1 |
| 2018 | Colonic responses to vitamin D and aspirin in African- and European-Americans1R01CA220329-01A1 · under PAR-15-093 | KUPFER, SONIA | UNIVERSITY OF CHICAGO, IL | $370,575 | ZRG1 |
| 2018 | Impact of germline variants on racial and ethnic differences in somatic mutation frequency1R01CA215151-01A1 · under PAR-15-093 | TOLAND, AMANDA EWART | OHIO STATE UNIVERSITY, OH | $356,088 | ZRG1 |
| 2017 | Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence1R01CA209798-01A1 · under PAR-15-093 | SETIAWAN, VERONICA WENDY | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $395,145 | ZRG1 |
| 2017 | Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)1R01CA204819-01A1 · under PAR-15-093 | PAL, TUYA | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $383,100 | ZRG1 |
| 2017 | Investigating serum exosomal annexin A2 in promoting aggressive TNBC in African American women1R01CA220273-01 · under PAR-15-093 | VISHWANATHA, JAMBOOR K. | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $380,476 | ZRG1 |
| 2017 | Consequences and mechanism of aberrant splicing in African American prostate cancer disparities1R01CA204806-01A1 · under PAR-15-093 | GARCIA-BLANCO, MARIANO A.LEE, NORMAN H | GEORGE WASHINGTON UNIVERSITY, DC | $376,409 | ZRG1 |
| 2017 | Evaluation of molecular determinants of racial disparity in triple-negative breast cancer1R01CA204555-01A1 · under PAR-15-093 | SHARMA, DIPALI | JOHNS HOPKINS UNIVERSITY, MD | $373,721 | ZRG1 |
| 2017 | Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer1R01CA220297-01 · under PAR-15-093 | PUTLURI, NAGIREDDY | BAYLOR COLLEGE OF MEDICINE, TX | $370,749 | ZRG1 |
| 2017 | Race-related alternative splicing: novel targets in prostate cancer1R01CA220314-01 · under PAR-15-093 | PATIERNO, STEVEN R | DUKE UNIVERSITY, NC | $361,013 | ZRG1 |
| 2016 | Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia1R01CA209829-01 · under PAR-15-093 | DOVAT, SINISAPAYNE, KIMBERLY J | LOMA LINDA UNIVERSITY, CA | $375,047 | ZRG1 |
| 2016 | Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk1R01CA204808-01 · under PAR-15-093 | GASKINS, REXMUTLU, ECE A.RIDLON, JASON MICHAELTUSSING-HUMPHREYS, LISA | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $367,150 | ZRG1 |
| 2016 | EPHA6 as a novel candidate driver gene in colon cancer1R01CA204549-01 · under PAR-15-093 | GUDA, KISHORE | CASE WESTERN RESERVE UNIVERSITY, OH | $362,569 | ZRG1 |
| 2016 | Biological implications of breast cancer protective variants in Latin American women with high Indigenous American ancestry1R01CA204797-01 · under PAR-15-093 | FEJERMAN, LAURA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $362,569 | ZRG1 |
| 2016 | MUC13 Mucin in Colorectal Cancer Health Disparity1R01CA204552-01 · under PAR-15-093 | CHAUHAN, SUBHASH C. | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $359,410 | ZRG1 |
| 2016 | Molecular causes and mechanistic underpinning of breast cancer racial disparity1R01CA204801-01 · under PAR-15-093 | SINGH, SEEMA | UNIVERSITY OF SOUTH ALABAMA, AL | $346,556 | ZRG1 |
| 2016 | Mitochondria in Prostate Cancer Diversity1R01CA204430-01 · under PAR-15-093 | SINGH, KESHAV K | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $336,263 | ZRG1 |
| 2016 | Modulation of host intrinsic immunity to reduce prostate cancer disparity1R01CA204786-01 · under PAR-15-093 | KARAN, DEV | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $313,306 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.